To assess the frequency of malignancy-associated 30-bp deletion variants of the latent membrane protein 1 (LMP-1) in benign conditions, a comparative sequence analysis was done using samples from 20 American children with acute infectious mononucleosis and 16 Swiss children with chronic tonsillar hyperplasia. The 30-bp deletion variant (LMP-1-del) was present in 66% of patients (12/ 20 with infectious mononucleosis and 12/16 with tonsillar hyperplasia). Two additional patients had a 3-bp deletion and an inframe insertion of 18 nucleotides, respectively. All but 1 isolate had numerous nonsilent point mutations. These data identify a hypervariable region within the Cterminus of LMP-1, in a domain required for maximal stimulation of NF-kB activity. These data demonstrate that LMP-1-del variants are frequent in acute infectious mononucleosis and tonsillar hyperplasia and identical to those observed in Epstein-Barr virus-associated AIDS-related lymphoma.
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Epstein-Barr virus (EBV) causes infectious mononucleosis
boxy-terminal NF-kB activation domain of LMP-1 has been associated with enhanced transforming potential compared with (IM) and is consistently associated with nasopharyngeal carcinoma (NPC) and lymphomas, especially in the immunocomthe oncoprotein prototype in vitro [7] . To further assess in vivo the relevance of this variant, we analyzed the LMP-1 Cpromised host. EBV infection is ubiquitous; the virus persists lifelong in latent form and can be detected in B lymphocytes terminus in DNA samples from American children with acute IM and Swiss children with EBV-associated chronic tonsillar and in oropharyngeal secretions [1] .
Latent membrane protein-1 (LMP-1) is considered a virus hyperplasia (TH). oncogene due to its ability to transform rodent fibroblasts in vitro and to render them tumorigenic in nude mice. It transMaterial and Methods forms human epithelial cells and inhibits their differentiation, induces DNA synthesis, up-regulates bcl-2 expression, and is sample. In the samples with LMP-1-del, an additional PCR using gene of poliovirus Sabin 1 strain (TCACCTATTCTAGA). Only 1 isolate (TH-1) corresponded exactly with the prototype B95.8.
Results
Most nucleotide changes were characterized by different amino acid substitutions, defining them as mutational ''hot spots.'' Sequencing results are summarized in figure 1. All deletions Independent triplicate amplification of every sample consistently and most point mutations occurred within the 100 bp from posishowed PCR products of identical size. In none of the patients tions 168324 to 168225, within the NF-kB activation domain were both LMP-1 variants found. A second sequencing of indeof LMP-1. Mutations were identified in ú75% of isolates at pendent amplification products was performed in 9 cases (includpositions 168225, 168257, 168258, 168266, 168295, and ing the 7 cases with the highest number of point mutations) to 168308; 76% of isolates had a point mutation at position 168357 further exclude sequence errors due to base misincorporation. that was no longer in the NF-kB activation domain. Between This internal control revealed complete sequence homology with position 168224 and the carboxy-terminal end (168160), only the initial results. Overall, four patterns of mutations were obone single point mutation (IM-7) was identified; 60% of the IM served in patients with IM and TH: an insertion in 1 isolate, samples and 75% of the TH samples showed a 30-bp deletion (positions 168285-168256). One IM-isolate (IM-8) had a 3-bp single point mutations and no deletion in 3 isolates, no 30-bp * Differences between groups B, C, and D are not significant (P ú .1).
deletion but an accumulation of point mutations in 7 isolates, in vivo relevance of these in vitro tumor-promoting effects. However, the high frequency of LMP-1-del in persons with and the 30-bp deletion plus point mutations in 24 isolates.
AIDS-related lymphoma, IM, and TH but not in asymptomatic The comparison of data from recent studies [3] [4] [5] [8] [9] [10] carriers is consistent with the hypothesis that this evolving with our data (table 1) First, our data identify LMP-1-del as a part of a hypervariable region different from a simple viral polymorphism. The presence of mutational hot spots, 3-and 30-bp deletions and an Discussion insertion, favors the generation of viral variants. Aware of the The LMP-1 variant with a C-terminal 30-bp deletion and possibility that variants with and without deletion might be 6 clustered point mutations (LMP-1-del) has been detected present in the same patient [4, 13, 14], we were not able to predominantly in AIDS-related lymphoma and Asian NPC [3- detect more than one variant by a very sensitive PCR approach 6]. Experimental studies with LMP-1 variants from biopsies in this collection. Viral inter-or intrastrain recombination durfrom persons with NPC (carrying LMP-1-del) indicated this ing EBV replication has been shown in oral hairy leukoplakia variant to be more tumorigenic [11] and less immunogenic [12] and NPC [6, 14] and fits with the frequent detection of LMPthan the LMP-1 prototype (B95.8) in mouse model systems.
1-del in persons with hyperplastic tonsils and in HIV-infected In particular, Li et al. [7] recently demonstrated that the deletion patients, in whom enhanced viral replication occurs. Alternaof these 30 bp in the LMP-1 prototype mediated enhanced tively, the accumulation of LMP-1 variants in situations with oncogenic potential in vitro. In vivo, the sequence variation of ongoing germinal center activity, particularly as seen in persons LMP-1-del in a region critical for the protein's half-life (by with TH, IM, and AIDS-associated lymphoproliferations, is prolongation of half-life) might lead to an accumulation of consistent with the generation of LMP-1 variants in germinal oncoprotein [2, 4] , consistent with an enhanced transforming center reactions, where physiologically somatic hypermutations activity in the infected cell. and isotype switching of immunoglobulin genes occur [15] . This sequence analysis of LMP-1 indicates the prevalence Second, the role of cellular immunity in controlling latent of LMP-1-del in 36 children with IM and HT. Although the EBV infection is well established and, in particular, is maintotal number of persons is epidemiologically limiting, the high tained after primary infection by specific clones of cytotoxic frequency of LMP-1-del in IM and HT, both benign and self-T lymphocytes targeted against latent EBV proteins, including LMP-1 [1] . Moreover, cellular immunodeficiency results in limiting processes, is surprising and may raise doubts on the
